YOLFTbeta
01

Whanin Pharm

016580 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

10,870.00KRW+130.00 (+1.21%)

Price History

Full chart

Market Stats

Previous Close10,740.00
Open10,740.00
Day Range10,700.00 – 10,870.00
52-Week Range9,160.00 – 12,140.00
Volume21.80K
Market Cap187.06B
P/E (TTM)0.00
Forward P/E15.48
Dividend Yield3.01%
Beta0.17
50-Day Avg10,117.60
200-Day Avg10,470.85

About

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin, external preparation, medical device, and sedative, hypnotic, and autonomic nervous system medications. The company was founded in 1978 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wonbum Lee
  • Employees631
  • HeadquartersWhanin Building, 11, Seoul, South Korea, 05855, Korea
  • Websitehttps://www.whanin.com

Leadership

  • Mr. Kwang-Sik LeeFounder & Chairman · b. 1947
  • Mr. Wonbum LeeCEO, President & Director · b. 1974
  • Mr. JeongBae GongExecutive Director & GM of Sales · b. 1975

Financials

Income Statement

Currency: KRW2009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue99.39B105.69B110.05B107.22B141.38B147.95B154.66B159.18B171.71B177.78B198.93B230.39B259.60B255.21B
Growth (%)-+6.34%+4.13%-2.57%+31.85%+4.65%+4.54%+2.92%+7.87%+3.54%+11.90%+15.81%+12.68%-1.69%
Cost of Revenue47.34B053.88B53.34B72.06B69.11B75.36B80.00B85.10B84.28B100.14B131.23B165.82B168.12B
Gross Profit52.04B105.69B56.17B53.88B69.32B78.85B79.30B79.18B86.60B93.49B98.79B99.16B93.78B87.10B
Gross Margin52.36%100.00%51.04%50.25%49.03%53.29%51.27%49.74%50.44%52.59%49.66%43.04%36.12%34.13%
Operating Expense34.19B85.35B35.89B35.59B47.69B49.19B51.96B53.02B58.18B62.22B68.98B68.99B72.28B74.08B
Operating Income17.86B20.34B20.28B18.29B21.63B29.65B27.34B26.16B28.42B31.28B29.81B30.17B21.50B13.02B
Operating Margin17.97%19.24%18.43%17.06%15.30%20.04%17.68%16.44%16.55%17.59%14.99%13.10%8.28%5.10%
EBITDA-----31.94B30.17B32.14B35.18B38.14B34.71B40.48B35.45B24.82B
EBITDA Margin-----21.59%19.51%20.19%20.49%21.45%17.45%17.57%13.65%9.72%
Net Income14.43B17.24B14.61B15.80B16.40B27.17B21.52B18.70B23.39B26.66B23.92B29.77B23.38B13.60B
Net Income Margin14.52%16.31%13.28%14.73%11.60%18.37%13.91%11.75%13.62%15.00%12.02%12.92%9.01%5.33%
R&D94.89M-647.77M647.77M827.77M1.17B647.77M993.27M3.31B2.66B3.33B1.07B771.13M1.22B
R&D as % of Total Revenue0.10%-0.59%0.60%0.59%0.79%0.42%0.62%1.93%1.50%1.67%0.47%0.30%0.48%
Interest Expense000000020.28M31.42M51.55M51.88M22.66M23.12M28.77M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.02%0.03%0.03%0.01%0.01%0.01%

Balance Sheet

Currency: KRW2009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets118.95B-166.11B181.43B243.44B274.84B287.69B304.88B329.56B353.19B369.37B401.23B424.71B478.89B
Total Liabilities10.51B-16.25B18.90B23.31B31.75B28.10B30.42B32.96B35.96B35.45B43.02B48.70B57.88B
Total Equity108.44B120.07B149.85B162.53B220.13B243.08B259.58B273.78B296.11B316.94B333.51B358.21B376.00B421.01B
Cash31.21B-33.99B50.82B57.77B39.93B38.51B17.98B36.07B64.06B36.78B45.37B43.15B63.58B

Cash Flow

Currency: KRW2009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow18.61B15.12B15.12B21.11B19.82B23.48B17.45B24.73B22.75B35.32B16.85B23.20B20.69B9.04B
Investing Cash Flow1.93B-721.11M-721.11M-462.50M---14.31B-40.12B603.42M-2.12B-38.94B---
Financing Cash Flow-7.02B620.69M620.69M-3.82B---4.58B-5.16B-5.19B-5.19B-5.13B---
Capital Expenditure2.18B2.68B2.68B5.06B7.46B19.31B4.10B2.76B7.99B4.39B33.65B31.49B29.38B6.18B
Free Cash Flow-----4.17B12.86B21.72B14.53B30.56B-50.91B-8.29B-8.69B2.86B
Dividends Paid3.03B3.64B3.64B3.82B3.82B3.82B4.58B4.58B4.58B4.58B4.58B4.58B4.58B4.58B
FCF to OCF-----17.75%73.69%87.81%63.86%86.52%-302.10%-35.75%-41.98%31.64%
Dividend Paid to FCF-----91.61%35.61%21.09%31.52%14.99%-9.00%-55.23%-52.72%160.08%

Earnings

Report DateMar 31, 2004Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jul 3, 2014Oct 1, 2014Feb 25, 2015Apr 3, 2015Jul 2, 2015Sep 30, 2015Feb 3, 2016May 3, 2016Jul 28, 2016Oct 27, 2016Feb 3, 2017Apr 23, 2017Jul 30, 2017Oct 30, 2017Jan 16, 2018Apr 25, 2018Jul 30, 2018Oct 28, 2018Jan 24, 2019Apr 29, 2019Jul 30, 2019Oct 28, 2019Feb 11, 2020Apr 27, 2020Aug 15, 2020Nov 27, 2020Mar 11, 2021May 13, 2021Jul 29, 2021Oct 31, 2021Feb 8, 2022Apr 27, 2022Jul 28, 2022Oct 27, 2022Feb 12, 2023Apr 28, 2023Jul 28, 2023Oct 31, 2023Feb 13, 2024Apr 30, 2024Jul 29, 2024Nov 1, 2024Feb 17, 2025Apr 28, 2025Jul 28, 2025Oct 30, 2025Dec 31, 2025Apr 28, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------------
EPS Actual42.14233.98241.32250.64228.00313.04147.72284.39228.92223.52249.66275.95285.5499.05301.80280.08274.08293.20330.08298.97309.52211.22427.52420.37284.28311.40312.14328.47122.04485.45495.41376.55422.39374.52410.11363.30261.00500.00183.19340.75200.52421.26317.87487.96304.82651.00449.00393.53252.65545.47365.00312.00344.65466.26572.80415.51495.65594.17406.69295.82234.77335.37208.80202.32113.85403.91416.53
Surprise-------------------------------------------------------------------
Timing------------------------After-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hours-After-hours-After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-market-After-hoursPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap187.06B
Enterprise Value119.87B
Trailing P/E0.00
Forward P/E15.48
PEG Ratio0.00
Price / Sales0.68
Price / Book0.44
Revenue (TTM)273.47B
Gross Profit (TTM)98.96B
EBITDA32.16B
Profit Margin7.48%
Operating Margin11.05%
Return on Equity5.08%
Return on Assets3.06%
Shares Outstanding18.48M
Shares Float14.15M
Beta0.17
Dividend Yield3.01%
Dividend Rate300.00
Payout Ratio26.39%

Dividends

20251×
300.00Dec 29, 2025
20241×
300.00Dec 27, 2024
20231×
300.00Dec 27, 2023
20221×
300.00Dec 28, 2022
20211×
300.00Dec 29, 2021
20201×
300.00Dec 29, 2020
20191×
300.00Dec 27, 2019
20181×
300.00Dec 27, 2018
20171×
300.00Dec 27, 2017
20161×
250.00Dec 28, 2016
20151×
250.00Dec 29, 2015
20141×
250.00Dec 29, 2014
20131×
250.00Dec 27, 2013
20121×
250.00Dec 27, 2012
20111×
250.00Dec 28, 2011
20101×
250.00Dec 29, 2010
20091×
250.00Dec 29, 2009
20081×
200.00Dec 29, 2008
20071×
200.00Dec 27, 2007
20061×
200.00Dec 27, 2006
20051×
150.00Dec 28, 2005
20041×
125.00Dec 29, 2004
20031×
125.00Dec 29, 2003
20021×
100.00Dec 27, 2002

Stock Splits

  • Apr 14, 20102:1
  • Apr 20, 20045:1